®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
January 19, 2018
ESSA Completes US$26 Million Equity Offering
Read the full press release
here
.
RELATED NEWS
See All News
Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million
The Globe and Mail | Vancouver readies for its position as a global pharma capital as B.C.’s biotech boom takes off
Registration for BBHIC2024 Now Open!
Bloom Burton & Co. Announces the 2024 Bloom Burton Award
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
Stephen Dilly Receives the 2023 Bloom Burton Award
Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension
GSK completes acquisition of BELLUS Health
Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy